Announcement on attending the 2024 semi-annual special group results briefing on pharmaceuticals and biological products
Conxino H Share Announcement
Investor Relations Activity Record Sheet for August 2024
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
CITIC Securities Co., Ltd.\'s verification opinion on the extension of some fund-raising investment projects of Cansino Biotech Co., Ltd.
Announcement on the postponement of some fund-raising investment projects
CITIC Securities Co., Ltd.\'s verification opinion on the use of temporarily idle funds raised by CITIC Securities Co., Ltd. for cash management
Notice on Using Temporarily Idle Raised Funds for Cash Management
Announcement of Resolutions of the Fourth Meeting of the Third Board of Supervisors
Special Report on the Deposit and Actual Use of Funds Raised for the Semiannual Year of 2024
Semi-annual evaluation report on the company\'s 2024 special action plan to improve quality, increase efficiency, and focus on return
Announcement on participating in the 2024 semi-annual report performance briefing for listed companies in Tianjin and online investor reception day
Announcement from Cansino Biologics Inc. listed in Hong Kong.
Announcement from Cansino Biologics Inc. listed in Hong Kong.
Investor Relations Activity Record Form for July 2024
Notice regarding the adjustment of H-share ownership method by one of the actual controlling persons and the signing of the Supplementary Agreement to the Unified Action Agreement.
Announcement on the increase in the company's H share holdings by some controlling shareholders
Announcement from Cansino Biologics Inc. listed in Hong Kong.
Investor relations activity record form for June 2024.
No Data